Committee allows Bharat Biotech to test third Covaxin shot, says report

Health Minister Harsh Vardhan on Friday said both Covaxin and Covishied are completely safe and immunogenic and as of now, there are no concerns about the safety of these vaccines

A subject expert committee (SEC) of India's drug regulator has allowed Bharat Biotech to conduct a phase 2 trial where participants will get a third shot of Covaxin six months after the second dose, Mint reported.

A phase 2 trial is used to test the immune response provided by the vaccine against a disease in a person. This differs from a phase 3 trial, which tests for efficacy, or what proportion of people are protected by the vaccine, said the paper.

The trial will be used to test the immune response provided by the vaccine against a disease in a